Prana has reported years ago that PBT2 treated animals lived longer and old animals started to behave as young animals. IMO these are signs that PBT2 was also a mitochondrion drug. Now most likely Prana has a more potent drug in this respect, just my opinion. If this is true the role of mitochondrion could be demonstrated by different biopsies ( muscle, skin or else) and these are simple and safe to do in comparison to getting spinal fluid. Of course analyses of these biopsies to find a change in mitochondrion are demanding. But even some simple physiological tests as pulmonary function tests and echo cardiogram or else could give interesting results, who knows. Every cell could work better even a test person feels and is still totally healthy. So IMO Phase 1 has some possibilities, just my opinion.
- Forums
- ASX - By Stock
- ATH
- Phase1 may demonstrate target engagement
Phase1 may demonstrate target engagement, page-8
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $1.937K | 645.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
77 | 96988980 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 655773 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
74 | 89988980 | 0.002 |
25 | 133640147 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 655773 | 2 |
0.004 | 151287339 | 54 |
0.005 | 8366584 | 12 |
0.006 | 16581534 | 13 |
0.007 | 53884874 | 26 |
Last trade - 10.00am 15/11/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online